Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.

Hayashino K, Fujii N, Murakami S, Masunari T, Yoshida I, Hashida R, Oka S, Fujiwara Y, Kitamura W, Kamoi C, Kondo T, Seike K, Fujiwara H, Asada N, Ennishi D, Fujii K, Maeda Y

Open source

DOI
10.1016/j.clml.2025.08.001
Published
2025 Nov
Container
Clinical lymphoma, myeloma & leukemia
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clml.2025.08.001,
  title = {Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.},
  author = {Hayashino K and Fujii N and Murakami S and Masunari T and Yoshida I and Hashida R and Oka S and Fujiwara Y and Kitamura W and Kamoi C and Kondo T and Seike K and Fujiwara H and Asada N and Ennishi D and Fujii K and Maeda Y},
  year = {2025},
  journal = {Clinical lymphoma, myeloma \& leukemia},
  doi = {10.1016/j.clml.2025.08.001},
  url = {https://doi.org/10.1016/j.clml.2025.08.001}
}

RIS

TY  - JOUR
TI  - Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.
AU  - Hayashino K
AU  - Fujii N
AU  - Murakami S
AU  - Masunari T
AU  - Yoshida I
AU  - Hashida R
AU  - Oka S
AU  - Fujiwara Y
AU  - Kitamura W
AU  - Kamoi C
AU  - Kondo T
AU  - Seike K
AU  - Fujiwara H
AU  - Asada N
AU  - Ennishi D
AU  - Fujii K
AU  - Maeda Y
PY  - 2025
JO  - Clinical lymphoma, myeloma & leukemia
DO  - 10.1016/j.clml.2025.08.001
UR  - https://doi.org/10.1016/j.clml.2025.08.001
ER  - 

APA

K, H., N, F., S, M., T, M., I, Y., R, H., S, O., Y, F., W, K., C, K., T, K., K, S., H, F., N, A., D, E., K, F., & Y, M. (2025). Comparison of Survival Outcomes Between Chimeric Antigen Receptor T-Cell Therapy Recipients With and Without Central Nervous System Involvement.. Clinical lymphoma, myeloma & leukemia. https://doi.org/10.1016/j.clml.2025.08.001

Source records